Antiviral Drug Cuts Cancer Risk in Hepatitis B (CME/CE)
BOSTON (MedPage Today) — For patients with chronic hepatitis B, long-term treatment with entecavir (Baraclude) significantly cut the risk of liver cancer, researchers reported.
Post a Comment
Antiviral Drug Cuts Cancer Risk in Hepatitis B (CME/CE)
BOSTON (MedPage Today) — For patients with chronic hepatitis B, long-term treatment with entecavir (Baraclude) significantly cut the risk of liver cancer, researchers reported.
Post a Comment
Antiviral Drug Cuts Cancer Risk in Hepatitis B (CME/CE)
BOSTON (MedPage Today) — For patients with chronic hepatitis B, long-term treatment with entecavir (Baraclude) significantly cut the risk of liver cancer, researchers reported.
Post a Comment
Antiviral Drug Cuts Cancer Risk in Hepatitis B (CME/CE)
BOSTON (MedPage Today) — For patients with chronic hepatitis B, long-term treatment with entecavir (Baraclude) significantly cut the risk of liver cancer, researchers reported.
All rights reserved. © UK. Site Map | Contact us | About us | Contributors | Supporters | Terms & Conditions
This site complies with the HONcode standard for trustworthy health information:
verify here.